46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46 - Wholesale trade
47 - Retail trade
49 - Land transport and transport via pipelines
52 - Warehousing, storage, and support activities for transport
68 - Real estate activities
72 - Scientific research and development activities
74 - Other professional, scientific and technical activities
45
2020 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | 0 | 0,1 | -∞ |
Gross profit (loss) | -0 | 0 | 0,2 | -∞ |
EBITDA | 0,1 | 0 | 0,2 | -∞ |
Short time liabilities | 1,5 | 1,5 | 0,6 | -59,5 |
Other operating costs | 0 | 0 | 0 | -∞ |
Income tax | -34,5 | |||
Equity capital | 0,5 | 0,7 | 0,8 | 8,2 |
Operating profit (EBIT) | -0 | 0 | 0,2 | -∞ |
Assets | 2,1 | 2,3 | 2,1 | -8,4 |
Net profit (loss) | -0 | 0 | 0,2 | -∞ |
Cash | 0,1 | -0,2 | 0,1 | 143,8 |
Net income from sale | 6,8 | 0 | 5,6 | -∞ |
Liabilities and provisions for liabilities | 1,5 | 1,5 | 1,3 | -16,5 |
Working assets | 2 | 2,2 | 2 | -9,3 |
Other income costs | 0 | 0 | 0,2 | -∞ |
Depreciation | 0,1 | 0 | 0 | -∞ |
Basic operational activity income | 79,5 | |||
% | % | % | p.p. | |
Profitability of capital | -1,7 | 0 | 18,9 | 18,9 |
Equity capital to total assets | 25,7 | 32,7 | 38,7 | 6 |
Gross profit margin | -0,1 | 2,9 | 3 | |
EBITDA Margin | 1 | 4,4 | 3,4 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 82 | 2 147 483 648 | 40 | -2 147 483 608 |
Current financial liquidity indicator | 1.328101634979248 | 1.4777722358703613 | 3.3067986965179443 | 1,8 |
Net dept to EBITDA | 0.32856449484825134 | 2.2912790775299072 | 2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane